| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 08/01/2001 | CN1305821A Medicine for treating CO poisoning |
| 07/31/2001 | US6268398 Aromatic guanidine derivatives |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053285A1 Food product and process |
| 07/26/2001 | CA2397565A1 Food product and process |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/25/2001 | EP1118617A1 Compounds with an antioxidant acitivity, compositions useful as food integrators containing them and process for their preparation |
| 07/25/2001 | EP1117695A1 Biocompatible polymers, preparation method and compositions containing same |
| 07/25/2001 | EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 07/25/2001 | EP1117396A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 07/24/2001 | US6265425 Side effect reduction; retinoic acid metabolism blocking agent |
| 07/24/2001 | US6265420 Aftertreatment; sustained release |
| 07/24/2001 | US6264966 Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 07/24/2001 | CA2240594C 2,7-substituted octahydro-pyrrolo¬1,2-a|pyrazine derivatives |
| 07/19/2001 | WO2001051473A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | WO2000009616A8 Biologically active fraction of vegetable melanin, process for its production and its use |
| 07/19/2001 | US20010008933 Novel disulfides and thiol compounds |
| 07/19/2001 | US20010008881 Method for the augmentation of gene expression |
| 07/18/2001 | CN1303713A Health-care composition for preventing and curing radiation damage |
| 07/18/2001 | CN1068517C Use of 2(3) tertiary butyl-4-hydroxy-anisole in preparation of drug for preventing and curing tissue organ traumatic disease |
| 07/17/2001 | US6262111 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 07/12/2001 | WO2001049851A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | WO2001049312A2 O-superfamily conotoxin peptides |
| 07/12/2001 | WO2001049308A1 Novel immune enhancing compositions |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049285A1 Flavonoid drug and dosage form, its production and use |
| 07/12/2001 | WO2001002391A3 Bicyclic aromatic compounds for treating drug addiction |
| 07/12/2001 | US20010007875 Antidiabetic agents |
| 07/12/2001 | US20010007693 Food products having enhanced cocoa polyphenol content and processes for producing the same |
| 07/12/2001 | CA2733819A1 Iron chelator delivery system |
| 07/12/2001 | CA2396529A1 O-superfamily conotoxin peptides |
| 07/12/2001 | CA2396239A1 Novel immune enhancing compositions |
| 07/12/2001 | CA2395625A1 Progenitor cell preservation factors and related methods and products |
| 07/11/2001 | EP1114031A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 07/11/2001 | EP1113805A1 Inhibition of toxic materials or substances using dendrimers |
| 07/11/2001 | CN1302650A 'Hehe' ointment and its preparing process |
| 07/11/2001 | CN1302629A Buccal lozenge of notoginseng flower |
| 07/11/2001 | CN1068225C Smoking health-care product |
| 07/10/2001 | US6258828 Chelating agents and their metal chelates for treating free radical induced conditions |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2000066138A3 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue |
| 07/05/2001 | US20010006966 Use of 1- (aminoalkyl) -3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/04/2001 | EP1112005A1 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid |
| 07/04/2001 | CN1302209A Polyol-IFN-beta conjugates |
| 07/04/2001 | CN1301569A Formulation for clearing away heat and toxic material |
| 07/04/2001 | CN1067878C Process for preparing anti-dote of soman intoxication |
| 07/03/2001 | US6255344 Histidine derivatives, preparation, process, and their use as free antiradical agents |
| 07/03/2001 | CA2012115C Iodinated somatostatins |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2000075144A3 Peroxynitrite decomposition catalysts and methods of use thereof |
| 06/28/2001 | DE19964224A1 New calcium complex of oxa-diaza-phosphaundecane derivative MS-325, useful as stabilizer for diagnostic compositions containing gadolinium complex of MS-325 and as antidote for heavy metal poisoning |
| 06/27/2001 | CN1301167A Treatment of organophosphate poisoning |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1300593A Medical application of pseudo-paraquilon F11 |
| 06/26/2001 | US6251935 Administration of a racemic alpha-lipoic acid, enantiomers and pharmaceutically acceptable salts, amides, esters or thioester, in reduced or oxidized form as antimigraine agent |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |
| 06/21/2001 | WO2001043712A1 Catechol oximes and their use in cosmetic and dermatological preparations |
| 06/21/2001 | WO2001043697A2 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 06/21/2001 | WO2000061191A9 Heat stable coated colloidal iron oxides |
| 06/21/2001 | DE19960105A1 Catecholoxime und ihre Verwendung in kosmetischen und dermatologischen Zubereitungen Catecholoxime and their use in cosmetic and dermatological preparations |
| 06/21/2001 | DE19957318A1 Beeinflussung von TGF-Beta durch Proteolytische Enzyme Influence of TGF-beta by proteolytic enzymes |
| 06/21/2001 | CA2393972A1 Cyclopenteneone derivatives |
| 06/21/2001 | CA2393301A1 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 06/20/2001 | EP1107996A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP1107723A2 A carotenoid composition containing phytoene and phytofluene |
| 06/20/2001 | CN1299676A Fatigue relieving medicine for driver |
| 06/20/2001 | CN1299669A Chinese medicine for treating several kinds of common ailment |
| 06/20/2001 | CN1067392C Stable crystalline tetrahydrofolic acid salts |
| 06/20/2001 | CN1067252C Cosmetics or pharmaceutical composition and use of antioxidation system in said composition |
| 06/14/2001 | WO2001042462A2 Phospholipase a2 inhibitory peptides from python reticulatus |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
| 06/14/2001 | WO2000068255A3 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/13/2001 | EP1105734A2 Homer interacting proteins |
| 06/13/2001 | EP1105121A1 Ascorbate-isoquercetin compositions |
| 06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
| 06/07/2001 | WO2001040213A1 Neutralizing agent for toxin of microorganism belonging to the genus clostridium |
| 06/07/2001 | WO2001039723A2 Triazospiro compounds having nociceptin receptor affinity |
| 06/06/2001 | EP1104446A1 Biologically active fraction of vegetable melanin, process for its production and its use |
| 06/06/2001 | CN1298306A Treatment of i (C. Difficile) toxin B associated conditions |
| 06/06/2001 | CN1297850A Active oxygen eliminating agent concentrated liquid and its producing process and active oxygen eliminating agent powder |
| 06/06/2001 | CN1066727C Anti-migraine indole derivative salts |
| 06/05/2001 | US6242473 Administering histamine |
| 06/05/2001 | US6242005 Crushed grape extract solvent extracted with acetone and ethyl acetate |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |
| 05/31/2001 | WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001037830A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 05/31/2001 | WO2001037819A2 Use of indirubine derivatives for making medicines |
| 05/31/2001 | WO2001005411A8 Compositions addressing inflammation and/or degenerative disorders |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |